Aravind Swaminathan, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Swaminathan’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A95939 · Current
Licensed to practise in California · since 2006 · expires 2027-10-31 · University of Pennsylvania School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$95,536
Medicare paid this office $95,536 for 1,072 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 213 | $20,197 | $75 |
| Long return visit (40+ min) | 84 | $14,993 | $121 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 234 | $13,889 | $58 |
| Short return visit (20+ min) | 167 | $9,683 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $3,196 | $107 |
See all 23 services
| Return visit (30+ min) | 213 | $20,197 | $75 |
| Long return visit (40+ min) | 84 | $14,993 | $121 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 234 | $13,889 | $58 |
| Short return visit (20+ min) | 167 | $9,683 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $3,196 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,842 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 294 | $2,657 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 121 | $2,518 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 89 | $2,518 | $22 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,309 | $115 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 42 | $1,661 | $28 |
| Short return visit | 73 | $1,586 | $20 |
| New patient visit (45+ min) | 13 | $1,230 | $95 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,089 | $73 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 27 | $955 | $30 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 39 | $658 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 39 | $431 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 27 | $403 | $15 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 19 | $393 | $20 |
| Ultrasound of heart, follow-up | 13 | $335 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $264 | $10 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 11 | $252 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 32 | $175 | $5 |
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
1,072 Original Medicare patients in 2024. Average age 74 · Under 65 12% · 85 and older 18% · Women 47% · Also on Medicaid 79% · Health risk score 2.41. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 52% · Heart failure 48% · Coronary heart disease 45% · Atrial fibrillation 41% · Chronic kidney disease 38% · Depression 22% · COPD 21% · Dementia 18% · Stroke 17% · Cancer 13%.
The office billed $1,093,732, Medicare allowed $134,450 and paid $95,536; for 2,127 services of 49 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,072 | 2,127 | 74 | 2.41 | $1,093,732 | $95,536 |
| 2023 | 829 | 1,647 | 73 | 2.33 | $885,855 | $81,279 |
| 2022 | 994 | 1,993 | 73 | 2.13 | $890,525 | $88,611 |
| 2021 | 857 | 1,399 | 73 | 2.28 | $572,916 | $55,982 |
| 2020 | 800 | 1,288 | 71 | 2.56 | $443,263 | $44,564 |
| 2019 | 1,145 | 2,331 | 71 | 2.36 | $1,030,072 | $88,336 |
| 2018 | 547 | 763 | 71 | 2.03 | $340,557 | $29,302 |
| 2016 | 544 | 843 | 70 | 2.32 | $268,399 | $33,927 |
| 2015 | 622 | 890 | 71 | 1.97 | $357,956 | $46,508 |
| 2014 | 653 | 1,029 | 70 | 1.89 | $338,337 | $49,439 |
| 2013 | 442 | 633 | 70 | 2.01 | $194,907 | $34,371 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Return visit (30+ min) | 158 | $16,869 | $76 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 171 | $10,102 | $58 |
| Short return visit (20+ min) | 110 | $5,909 | $48 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $5,100 | $464 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,591 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $4,424 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $4,378 | $74 |
| Telephone medical discussion with physician, 11-20 minutes | 42 | $3,418 | $47 |
| Short return visit | 94 | $2,898 | $27 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,541 | $121 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 93 | $1,679 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 194 | $1,593 | $7 |
| Long return visit (40+ min) | 12 | $1,414 | $118 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 50 | $1,212 | $17 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 35 | $1,174 | $25 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,171 | $90 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 31 | $1,091 | $29 |
| Programming of dual lead pacemaker system | 20 | $659 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 28 | $523 | $19 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 15 | $359 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 28 | $348 | $12 |
| Ultrasound of heart, follow-up | 13 | $321 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $236 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $155 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 23 | $112 | $5 |
2022: 27 services
| Return visit (30+ min) | 143 | $14,711 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 142 | $9,057 | $61 |
| Telephone medical discussion with physician, 11-20 minutes | 89 | $7,100 | $54 |
| Short return visit (20+ min) | 124 | $6,895 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $5,331 | $113 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $4,645 | $221 |
| Short return visit | 146 | $4,458 | $26 |
| Long return visit (40+ min) | 19 | $3,116 | $135 |
| Programming of dual lead pacemaker system | 104 | $2,870 | $23 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,598 | $137 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 293 | $2,581 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,172 | $72 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | $1,987 | $83 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 33 | $1,947 | $29 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 46 | $1,694 | $21 |
| Programming of multiple lead implantable defibrillator system | 21 | $1,381 | $51 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 57 | $1,067 | $19 |
| Programming of dual lead implantable defibrillator system | 15 | $1,014 | $51 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 45 | $683 | $15 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 24 | $630 | $23 |
| Telephone medical discussion with physician, 5-10 minutes | 22 | $532 | $24 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 14 | $515 | $34 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 46 | $486 | $11 |
| Programming of single lead pacemaker system | 18 | $448 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 20 | $329 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 48 | $236 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 20 | $229 | $11 |
2021: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 170 | $10,689 | $61 |
| Return visit (30+ min) | 46 | $4,645 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $4,295 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $3,844 | $75 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 365 | $3,442 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,960 | $228 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,818 | $148 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 41 | $2,039 | $25 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 43 | $1,610 | $22 |
| Telephone medical discussion with physician, 5-10 minutes | 40 | $1,106 | $25 |
| Programming of dual lead pacemaker system | 36 | $1,076 | $28 |
| Short return visit (20+ min) | 17 | $1,052 | $62 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $991 | $47 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 43 | $688 | $16 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 22 | $554 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 43 | $479 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $243 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 55 | $242 | $4 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $164 | $12 |
2020: 15 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 106 | $7,135 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $6,394 | $79 |
| Return visit (30+ min) | 73 | $4,537 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $4,134 | $138 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 393 | $3,519 | $7 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 37 | $2,205 | $32 |
| Telephone medical discussion with physician, 11-20 minutes | 50 | $2,016 | $40 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 33 | $1,146 | $24 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $936 | $67 |
| Programming of dual lead pacemaker system | 31 | $856 | $26 |
| Telephone medical discussion with physician, 5-10 minutes | 30 | $676 | $22 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 25 | $623 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 35 | $544 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 35 | $365 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 52 | $213 | $4 |
2019: 20 services
| Return visit (30+ min) | 224 | $21,428 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 197 | $12,492 | $62 |
| Short return visit (20+ min) | 263 | $12,049 | $37 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 57 | $7,583 | $66 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $6,113 | $437 |
| Programming of dual lead pacemaker system | 147 | $5,465 | $27 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $3,960 | $116 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 434 | $3,856 | $7 |
| Programming of dual lead implantable defibrillator system | 27 | $2,148 | $44 |
| Programming of multiple lead implantable defibrillator system | 25 | $1,852 | $49 |
| Programming of single lead pacemaker system | 43 | $1,179 | $24 |
| Short return visit | 56 | $918 | $16 |
| Programming of single lead implantable defibrillator system | 17 | $909 | $34 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 53 | $884 | $17 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $713 | $42 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 53 | $605 | $11 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 24 | $585 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 76 | $421 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 24 | $410 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 24 | $275 | $11 |
2018: 12 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 106 | $6,819 | $64 |
| Return visit (30+ min) | 79 | $5,803 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $4,097 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,904 | $112 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 196 | $1,594 | $7 |
| Programming of dual lead pacemaker system | 30 | $1,083 | $35 |
| Short return visit (20+ min) | 19 | $829 | $44 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 29 | $574 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 29 | $391 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 23 | $376 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 49 | $306 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 23 | $256 | $11 |
2016: 8 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 146 | $8,200 | $55 |
| Return visit (30+ min) | 105 | $7,781 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $4,010 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $3,858 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,852 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 203 | $1,809 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 72 | $1,341 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 77 | $940 | $12 |
2015: 10 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 390 | $21,840 | $55 |
| Return visit (30+ min) | 87 | $8,457 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $3,737 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,140 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,066 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,817 | $91 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 77 | $1,461 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 105 | $1,288 | $12 |
| Short return visit (20+ min) | 12 | $576 | $44 |
| Ultrasound of heart, follow-up | 13 | $340 | $23 |
2014: 10 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 305 | $15,948 | $52 |
| Return visit (30+ min) | 101 | $10,009 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 56 | $6,436 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $5,614 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 128 | $2,127 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 169 | $1,877 | $11 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,863 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,201 | $86 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 23 | $1,157 | $50 |
| Ultrasound of heart, follow-up | 21 | $438 | $21 |
2013: 8 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 167 | $9,029 | $53 |
| Return visit (30+ min) | 68 | $5,976 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $4,381 | $115 |
| New patient visit (45+ min) | 35 | $3,845 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $3,609 | $61 |
| Ultrasound of heart | 62 | $2,235 | $35 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 44 | $727 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 66 | $713 | $11 |
Medicaid work
$39,367 in 2024
Medicaid paid $39,367 for 6,799 billed services this clinician did in 2024, up to 137 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 534 | $9,161 |
| Return visit (30+ min) | 573 | $7,638 |
| Long return visit (40+ min) | 335 | $7,505 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 965 | $3,753 |
| Medication therapy management service(s) provided by a pharmacist, individual, face-to-face with patient, with assessment and intervention if provided; initial 15 minutes, established patient | 246 | $2,963 |
| Medication therapy management service(s) provided by a pharmacist, individual, face-to-face with patient, with assessment and intervention if provided; each additional 15 minutes (List separately in addition to code for primary service) | 275 | $2,635 |
| Short return visit (20+ min) | 322 | $1,866 |
| Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead pacemaker system, or leadless pacemaker system | 291 | $1,092 |
| Short return visit | 175 | $758 |
| CARDIOVASCULAR STRESS TEST | 137 | $571 |
| CARDIOVASCULAR STRESS TEST | 136 | $365 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 126 | $353 |
| 2024 | 6,799 | 27 | 137 | $39,367 |
| 2023 | 3,966 | 24 | 124 | $24,534 |
| 2022 | 3,674 | 14 | 125 | $28,087 |
| 2021 | 2,444 | 9 | 122 | $19,755 |
| 2020 | 2,214 | 13 | 125 | $15,642 |
| 2019 | 3,383 | 10 | 93 | $20,851 |
| 2018 | 2,782 | 11 | 94 | $18,598 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 472 | $7,576 |
| Return visit (30+ min) | 774 | $5,397 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 709 | $2,423 |
| Medication therapy management service(s) provided by a pharmacist, individual, face-to-face with patient, with assessment and intervention if provided; each additional 15 minutes (List separately in addition to code for primary service) | 50 | $1,969 |
| Short return visit (20+ min) | 376 | $1,422 |
| CARDIOVASCULAR STRESS TEST | 149 | $884 |
| Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead pacemaker system, or leadless pacemaker system | 210 | $823 |
| Short return visit | 322 | $820 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 164 | $744 |
| Medication therapy management service(s) provided by a pharmacist, individual, face-to-face with patient, with assessment and intervention if provided; initial 15 minutes, established patient | 12 | $699 |
| CARDIOVASCULAR STRESS TEST | 149 | $569 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 81 | $546 |
2022
| Return visit (30+ min) | 555 | $5,843 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 300 | $5,592 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 978 | $4,392 |
| Short return visit (20+ min) | 579 | $3,425 |
| Medication therapy management service(s) provided by a pharmacist, individual, face-to-face with patient, with assessment and intervention if provided; initial 15 minutes, established patient | 38 | $2,125 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 161 | $1,149 |
| Short return visit | 354 | $1,078 |
| CARDIOVASCULAR STRESS TEST | 148 | $1,029 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 95 | $852 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 172 | $745 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 57 | $700 |
| CARDIOVASCULAR STRESS TEST | 149 | $664 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 386 | $6,865 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,359 | $5,872 |
| Return visit (30+ min) | 218 | $3,886 |
| Short return visit (20+ min) | 142 | $1,584 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 62 | $533 |
| CARDIOVASCULAR STRESS TEST | 104 | $395 |
| CARDIOVASCULAR STRESS TEST | 104 | $252 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 15 | $222 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 54 | $146 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,058 | $5,011 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 198 | $4,048 |
| Return visit (30+ min) | 211 | $2,271 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 180 | $1,513 |
| CARDIOVASCULAR STRESS TEST | 139 | $745 |
| Short return visit (20+ min) | 122 | $557 |
| CARDIOVASCULAR STRESS TEST | 139 | $470 |
| Service | 14 | $443 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 14 | $229 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 16 | $157 |
| Short return visit | 99 | $125 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 12 | $72 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 409 | $7,756 |
| Return visit (30+ min) | 568 | $3,334 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,052 | $3,153 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 298 | $2,560 |
| Short return visit (20+ min) | 598 | $1,260 |
| CARDIOVASCULAR STRESS TEST | 182 | $971 |
| CARDIOVASCULAR STRESS TEST | 182 | $621 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 52 | $606 |
| Service | 15 | $512 |
| Short return visit | 27 | $79 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 499 | $8,435 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,012 | $3,455 |
| Return visit (30+ min) | 570 | $2,930 |
| CARDIOVASCULAR STRESS TEST | 212 | $1,141 |
| CARDIOVASCULAR STRESS TEST | 212 | $736 |
| Short return visit (20+ min) | 168 | $542 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 53 | $536 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 19 | $415 |
| Service | 12 | $409 |
| Short return visit | 12 | $0 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 13 | $0 |
Drugs they prescribed that Part D paid
$712,693
Pharmacies billed $712,693 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,895) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,293 generic and 602 brand-name prescriptions · $712,693 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Entresto | 289 | $348,601 | $1,206 |
| Jardiance | 182 | $234,959 | $1,291 |
| Eliquis | 71 | $78,512 | $1,106 |
| Xarelto | 20 | $26,732 | $1,337 |
| Metoprolol | 216 | $3,510 | $16 |
See all 24 drugs
| Entresto | 289 | $348,601 | $1,206 |
| Jardiance | 182 | $234,959 | $1,291 |
| Eliquis | 71 | $78,512 | $1,106 |
| Xarelto | 20 | $26,732 | $1,337 |
| Metoprolol | 216 | $3,510 | $16 |
| Bumetanide | 50 | $3,011 | $60 |
| Isosorbide Dinitrate | 27 | $2,813 | $104 |
| Carvedilol | 214 | $1,641 | $8 |
| Furosemide | 172 | $994 | $6 |
| Eplerenone | 14 | $898 | $64 |
| Hydralazine | 51 | $895 | $18 |
| Isosorbide Mononitrate Er | 53 | $814 | $15 |
| Ranolazine Er | 19 | $684 | $36 |
| Amiodarone | 11 | $683 | $62 |
| Spironolactone | 119 | $544 | $5 |
| Atorvastatin | 74 | $499 | $7 |
| Digoxin | 27 | $433 | $16 |
| Losartan | 57 | $297 | $5 |
| Potassium Chloride | 12 | $294 | $24 |
| Clopidogrel | 20 | $262 | $13 |
| Nitroglycerin | 24 | $245 | $10 |
| Amlodipine Besylate | 46 | $206 | $4 |
| Lisinopril | 45 | $127 | $3 |
| Metoprolol | 17 | $104 | $6 |
Year by year
| 2024 | 1,895 | 259 | 0% (0) | 32% | $712,693 |
| 2023 | 1,853 | 238 | 0% (0) | 30% | $534,881 |
| 2022 | 1,745 | 232 | 0% (0) | None | $306,712 |
| 2021 | 1,695 | 204 | 0% (0) | 24% | $245,652 |
| 2020 | 1,829 | 218 | 0% (0) | 30% | $179,459 |
| 2019 | 1,570 | 216 | 0% (0) | 26% | $128,173 |
| 2018 | 1,301 | 201 | None | 18% | $76,026 |
| 2017 | 1,142 | 175 | 0% (0) | 20% | $67,422 |
| 2016 | 1,022 | 164 | 0% (0) | 17% | $55,659 |
| 2015 | 854 | 153 | 0% (0) | 15% | $38,243 |
| 2014 | 651 | 115 | 0% (0) | 17% | $21,492 |
| 2013 | 437 | 79 | 0% (0) | 17% | $13,043 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Entresto | 310 | $291,635 | $941 |
| Jardiance | 133 | $121,618 | $914 |
| Eliquis | 43 | $53,038 | $1,233 |
| Xarelto | 20 | $30,330 | $1,516 |
| Bumetanide | 63 | $4,789 | $76 |
| Carvedilol | 244 | $4,126 | $17 |
| Isosorbide Dinitrate | 50 | $3,544 | $71 |
| Metoprolol | 173 | $3,198 | $18 |
| Furosemide | 192 | $1,866 | $10 |
| Hydralazine | 81 | $1,510 | $19 |
| Atorvastatin | 49 | $1,490 | $30 |
| Spironolactone | 113 | $1,380 | $12 |
| Amiodarone | 35 | $1,167 | $33 |
| Isosorbide Mononitrate Er | 36 | $1,098 | $30 |
| Digoxin | 24 | $983 | $41 |
| Potassium Chloride | 18 | $717 | $40 |
| Losartan | 31 | $668 | $22 |
| Lisinopril | 63 | $590 | $9 |
| Nitroglycerin | 24 | $389 | $16 |
| Clopidogrel | 14 | $342 | $24 |
| Amlodipine Besylate | 32 | $304 | $10 |
| Metoprolol | 21 | $193 | $9 |
2022: 22 drugs
| Entresto | 244 | $185,646 | $761 |
| Jardiance | 47 | $36,590 | $779 |
| Eliquis | 35 | $30,955 | $884 |
| Isosorbide Dinitrate | 69 | $7,393 | $107 |
| Bumetanide | 40 | $4,255 | $106 |
| Carvedilol | 253 | $4,075 | $16 |
| Metoprolol | 184 | $3,453 | $19 |
| Furosemide | 200 | $1,821 | $9 |
| Isosorbide Mononitrate Er | 55 | $1,479 | $27 |
| Hydralazine | 73 | $1,453 | $20 |
| Atorvastatin | 66 | $1,222 | $19 |
| Amiodarone | 18 | $1,038 | $58 |
| Spironolactone | 91 | $938 | $10 |
| Digoxin | 23 | $915 | $40 |
| Nitroglycerin | 29 | $826 | $28 |
| Potassium Chloride | 20 | $659 | $33 |
| Lisinopril | 71 | $634 | $9 |
| Losartan | 50 | $581 | $12 |
| Clopidogrel | 18 | $319 | $18 |
| Torsemide | 11 | $317 | $29 |
| Amlodipine Besylate | 38 | $289 | $8 |
| Metoprolol | 37 | $186 | $5 |
2021: 22 drugs
| Entresto | 196 | $139,996 | $714 |
| Xarelto | 26 | $37,406 | $1,439 |
| Eliquis | 29 | $22,895 | $789 |
| Isosorbide Dinitrate | 68 | $7,719 | $114 |
| Bumetanide | 61 | $6,590 | $108 |
| Metoprolol | 198 | $4,344 | $22 |
| Carvedilol | 215 | $3,052 | $14 |
| Furosemide | 203 | $1,589 | $8 |
| Digoxin | 40 | $1,314 | $33 |
| Hydralazine | 91 | $1,300 | $14 |
| Isosorbide Mononitrate Er | 57 | $1,277 | $22 |
| Atorvastatin | 42 | $978 | $23 |
| Potassium Chloride | 27 | $706 | $26 |
| Spironolactone | 82 | $675 | $8 |
| Nitroglycerin | 21 | $628 | $30 |
| Losartan | 58 | $602 | $10 |
| Lisinopril | 90 | $601 | $7 |
| Clopidogrel | 28 | $451 | $16 |
| Amiodarone | 26 | $377 | $14 |
| Fosinopril | 11 | $226 | $21 |
| Amlodipine Besylate | 30 | $223 | $7 |
| Metoprolol | 17 | $123 | $7 |
2020: 23 drugs
| Entresto | 163 | $101,276 | $621 |
| Eliquis | 32 | $23,456 | $733 |
| Xarelto | 16 | $20,489 | $1,281 |
| Isosorbide Dinitrate | 46 | $5,808 | $126 |
| Bumetanide | 66 | $4,561 | $69 |
| Metoprolol | 191 | $3,391 | $18 |
| Carvedilol | 269 | $2,400 | $9 |
| Digoxin | 46 | $1,991 | $43 |
| Hydralazine | 78 | $1,773 | $23 |
| Potassium Chloride | 36 | $1,635 | $45 |
| Furosemide | 243 | $1,521 | $6 |
| Isosorbide Mononitrate Er | 78 | $1,452 | $19 |
| Nitroglycerin | 24 | $956 | $40 |
| Spironolactone | 128 | $766 | $6 |
| Losartan | 84 | $638 | $8 |
| Valsartan | 11 | $585 | $53 |
| Fosinopril | 22 | $495 | $23 |
| Atorvastatin | 29 | $483 | $17 |
| Lisinopril | 109 | $482 | $4 |
| Clopidogrel | 28 | $435 | $16 |
| Amlodipine Besylate | 38 | $236 | $6 |
| Amiodarone | 17 | $186 | $11 |
| Metoprolol | 11 | $67 | $6 |
2019: 25 drugs
| Entresto | 77 | $52,047 | $676 |
| Xarelto | 17 | $22,056 | $1,297 |
| Eliquis | 21 | $15,878 | $756 |
| Bumetanide | 60 | $6,128 | $102 |
| Metoprolol | 128 | $4,115 | $32 |
| Isosorbide Dinitrate | 37 | $3,739 | $101 |
| Carvedilol | 206 | $2,908 | $14 |
| Potassium Chloride | 39 | $2,046 | $52 |
| Furosemide | 230 | $1,730 | $8 |
| Hydralazine | 60 | $1,295 | $22 |
| Isosorbide Mononitrate Er | 56 | $1,014 | $18 |
| Atorvastatin | 49 | $901 | $18 |
| Digoxin | 16 | $797 | $50 |
| Nitroglycerin | 25 | $779 | $31 |
| Spironolactone | 113 | $697 | $6 |
| Digox | 15 | $694 | $46 |
| Lisinopril | 106 | $669 | $6 |
| Losartan | 66 | $613 | $9 |
| Clopidogrel | 37 | $464 | $13 |
| Fosinopril | 20 | $287 | $14 |
| Amiodarone | 20 | $278 | $14 |
| Amlodipine Besylate | 36 | $176 | $5 |
| Metoprolol | 30 | $171 | $6 |
| Metolazone | 12 | $143 | $12 |
| Benazepril | 19 | $95 | $5 |
2018: 21 drugs
| Entresto | 41 | $24,709 | $603 |
| Bumetanide | 30 | $6,857 | $229 |
| Isosorbide Dinitrate | 43 | $4,417 | $103 |
| Carvedilol | 220 | $2,170 | $10 |
| Metoprolol | 64 | $2,139 | $33 |
| Digox | 24 | $1,515 | $63 |
| Potassium Chloride | 22 | $1,190 | $54 |
| Furosemide | 178 | $1,054 | $6 |
| Hydralazine | 53 | $1,022 | $19 |
| Atorvastatin | 43 | $728 | $17 |
| Isosorbide Mononitrate Er | 29 | $683 | $24 |
| Nitroglycerin | 17 | $673 | $40 |
| Spironolactone | 86 | $612 | $7 |
| Losartan | 67 | $599 | $9 |
| Valsartan | 17 | $597 | $35 |
| Lisinopril | 93 | $581 | $6 |
| Clopidogrel | 41 | $510 | $12 |
| Fosinopril | 17 | $351 | $21 |
| Metoprolol | 50 | $287 | $6 |
| Amiodarone | 18 | $255 | $14 |
| Amlodipine Besylate | 30 | $142 | $5 |
2017: 19 drugs
| Xarelto | 15 | $16,101 | $1,073 |
| Entresto | 25 | $11,432 | $457 |
| Isosorbide Dinitrate | 40 | $4,588 | $115 |
| Bumetanide | 21 | $3,890 | $185 |
| Carvedilol | 237 | $1,942 | $8 |
| Digox | 24 | $1,534 | $64 |
| Metoprolol | 49 | $1,366 | $28 |
| Furosemide | 157 | $865 | $6 |
| Atorvastatin | 41 | $725 | $18 |
| Hydralazine | 40 | $694 | $17 |
| Fosinopril | 24 | $543 | $23 |
| Isosorbide Mononitrate Er | 26 | $499 | $19 |
| Clopidogrel | 33 | $493 | $15 |
| Metoprolol | 51 | $480 | $9 |
| Nitroglycerin | 14 | $463 | $33 |
| Spironolactone | 62 | $454 | $7 |
| Losartan | 68 | $452 | $7 |
| Lisinopril | 93 | $382 | $4 |
| Amlodipine Besylate | 24 | $120 | $5 |
2016: 21 drugs
| Xarelto | 12 | $12,101 | $1,008 |
| Entresto | 11 | $5,079 | $462 |
| Isosorbide Dinitrate | 45 | $4,145 | $92 |
| Carvedilol | 233 | $2,011 | $9 |
| Metoprolol | 43 | $2,005 | $47 |
| Digox | 17 | $1,254 | $74 |
| Atorvastatin | 37 | $818 | $22 |
| Furosemide | 136 | $779 | $6 |
| Isosorbide Mononitrate Er | 30 | $720 | $24 |
| Hydralazine | 39 | $669 | $17 |
| Nitrostat | 15 | $635 | $42 |
| Bumetanide | 11 | $559 | $51 |
| Fosinopril | 25 | $403 | $16 |
| Losartan | 47 | $399 | $8 |
| Lisinopril | 80 | $344 | $4 |
| Spironolactone | 55 | $302 | $5 |
| Clopidogrel | 19 | $267 | $14 |
| Metoprolol | 27 | $127 | $5 |
| Benazepril | 17 | $108 | $6 |
| Amlodipine Besylate | 18 | $78 | $4 |
| Simvastatin | 13 | $48 | $4 |
2015: 22 drugs
| Isosorbide Dinitrate | 37 | $4,654 | $126 |
| Bumetanide | 23 | $3,088 | $134 |
| Metoprolol | 30 | $1,727 | $58 |
| Potassium Chloride | 21 | $1,348 | $64 |
| Carvedilol | 146 | $1,330 | $9 |
| Digox | 17 | $963 | $57 |
| Atorvastatin | 36 | $887 | $25 |
| Furosemide | 109 | $834 | $8 |
| Isosorbide Mononitrate Er | 23 | $618 | $27 |
| Fosinopril | 40 | $565 | $14 |
| Hydralazine | 32 | $563 | $18 |
| Losartan | 57 | $486 | $9 |
| Nitrostat | 11 | $328 | $30 |
| Spironolactone | 41 | $258 | $6 |
| Lisinopril | 34 | $211 | $6 |
| Metoprolol | 27 | $146 | $5 |
| Benazepril | 14 | $141 | $10 |
| Simvastatin | 32 | $134 | $4 |
| Clopidogrel | 11 | $121 | $11 |
| Hydrochlorothiazide | 13 | $61 | $5 |
| Amlodipine Besylate | 19 | $54 | $3 |
| Atenolol | 11 | $45 | $4 |
2014: 20 drugs
| Isosorbide Dinitrate | 50 | $6,569 | $131 |
| Carvedilol | 118 | $1,655 | $14 |
| Metoprolol | 25 | $1,595 | $64 |
| Hydralazine | 32 | $1,044 | $33 |
| Bumetanide | 12 | $1,015 | $85 |
| Potassium Chloride | 16 | $909 | $57 |
| Fosinopril | 46 | $704 | $15 |
| Furosemide | 68 | $550 | $8 |
| Atorvastatin | 17 | $543 | $32 |
| Isosorbide Mononitrate Er | 15 | $452 | $30 |
| Clopidogrel | 12 | $452 | $38 |
| Nitrostat | 18 | $410 | $23 |
| Simvastatin | 40 | $325 | $8 |
| Benazepril | 17 | $264 | $16 |
| Losartan | 17 | $231 | $14 |
| Metoprolol | 21 | $184 | $9 |
| Amlodipine Besylate | 24 | $164 | $7 |
| Spironolactone | 27 | $126 | $5 |
| Hydrochlorothiazide | 16 | $110 | $7 |
| Amiodarone | 11 | $104 | $9 |
2013: 12 drugs
| Isosorbide Dinitrate | 27 | $3,507 | $130 |
| Carvedilol | 81 | $1,408 | $17 |
| Hydralazine | 28 | $1,170 | $42 |
| Metoprolol | 12 | $802 | $67 |
| Fosinopril | 28 | $600 | $21 |
| Isosorbide Mononitrate Er | 18 | $495 | $28 |
| Furosemide | 63 | $466 | $7 |
| Simvastatin | 14 | $192 | $14 |
| Losartan | 13 | $184 | $14 |
| Amlodipine Besylate | 19 | $179 | $9 |
| Spironolactone | 22 | $147 | $7 |
| Hydrochlorothiazide | 20 | $69 | $3 |
Money from drug and device companies
$5,941 in 2025
| 2025 | 3 | 12 | $4,000 | $5,941 |
| 2024 | 2 | 2 | None | $60 |
| 2023 | 1 | 12 | None | $951 |
| 2021 | 2 | 9 | $7,725 | $7,742 |
| 2020 | 1 | 9 | $12,450 | $12,450 |
| 2019 | 1 | 10 | $22,245 | $22,245 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
BioTrace Medical, Inc.
$435,007
Held by this doctor · 2021, 2020, 2019 · Common Stock, Common Stock Options and Preferred Stock, Common Stock + Preferred Stock · amount invested $111,782
Published ownership or investment in a drug or device company. This is not proof that care is biased.
A payment is not proof that care is biased.
| Merit Medical Systems | None | $4,000 | 2 payments
|
| Biotronik | Solia | $1,772 | 9 payments
|
| Medtronic | Aurora Ev-Icd Mri Surescan | $170 | 1 payment
|
See all 12 published payments
| Merit Medical Systems | Consulting · 2025-09-10 | None | $1,000 |
| Medtronic | Meals · 2025-03-27 | Aurora Ev-Icd Mri Surescan | $170 |
| Biotronik | Meals · 2025-03-22 | Solia | $45 |
| Biotronik | Meals · 2025-03-21 | Solia | $40 |
| Biotronik | Meals · 2025-03-21 | None | $84 |
| Biotronik | Meals · 2025-03-21 | None | $93 |
| Biotronik | Meals · 2025-03-21 | None | $41 |
| Biotronik | Meals · 2025-03-21 | None | $46 |
| Biotronik | Meals · 2025-03-21 | None | $14 |
| Biotronik | Travel · 2025-03-07 | None | $1,022 |
| Biotronik | Travel · 2025-03-07 | None | $387 |
| Merit Medical Systems | Consulting · 2025-02-26 | None | $3,000 |
See earlier years (2024, 2023, 2021, 2020, 2019)
2024: $60
| iRhythm Technologies | Zio Xt Patch | $39 | 1 payment
|
| Medtronic | Micra | $21 | 1 payment
|
2023: $951
| Medtronic | Micra | $951 | 12 payments
|
2021: $7,742
| BioTrace Medical | None | $7,725 | 1 payment
|
| Medtronic | Micra | $17 | 1 payment
|
2020: $12,450
| BioTrace Medical | None | $12,450 | 1 payment
|
2019: $22,245
| BioTrace Medical | None | $22,245 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1407046402
- Licence
- CA A95939California A95939: Current · expires 2027-10-31
- Trained
- Perelman School of Med at the University of Pennsylvania, 2003
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 925 Waverley St, Apt. 206, Palo Alto, CA, 94301
- NPI first listed
- 2007-07-26
- NPI last updated
- 2007-07-26
This is when the NPI record was last certified, not a medical board exam.